Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea

Japanese Journal of Clinical Oncology

Volumn 30, Issue 7, 2000, Pages 310-312

  Tabata, Masahiko ^a   Imagawa, Shigehiko ^b   Tarumoto, Takahisa ^a   Ohmine, Ken ^a   Hatake, Kiyohiko ^a   Miura, Yasusada ^a   Ozawa, Keiya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Acute myelogenous leukemia; Blastic crisis; Essential thrombocythemia; Hydroxyurea; Myeloproliferative disorders

Indexed keywords

ACLARUBICIN; CARBOQUONE; CYTARABINE; HYDROXYUREA; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANEMIA; ARTICLE; BLAST CELL; BLAST CELL CRISIS; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOCYTOSIS; MYELOFIBROSIS; THROMBOCYTHEMIA; THROMBOCYTOPENIA;

EID: 0033819160     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyd084     Document Type: Article

References (16)

1. Essential thrombocythemias: Clinical evolutionary and biological data
2. Essential thrombocythemia and leukemic transformation
3. Essential thrombocythemia: Another 'heterogeneous disease' better understood?
4. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: High proportion of cases with 17p deletion
5. Essential thromobocythemia: An interim report from the Polycythemia Vera Study Group
6. Essential thrombocythemia: A clonal disorder of hematopoietic stem cell
7. Mechanism of action of hydroxyurea
8. Treatment of polycythemia vera with hydroxyurea
9. Hydroxyurea in the treatment of polycythemia vera: A prospective study of 100 patients over a 20-year period
10. Essential thrombocythemia (ET) developing into refractory anemia and complicated by acute myeloid leukemia
11. Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent
12. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations
13. The 17p-syndrome: A distinct myelodysplastic syndrome entity?
14. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases
15. Genetic lesions associated with blastic transformation of polycythemia
16. Essential thromobocythemia terminating in acute leukemia with minimal myeloid differentiation - A brief review of recent literature